OTCMKTS:ERGO - Entia Biosciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.01 -0.01 (-50.00 %) (As of 02/21/2019 04:00 PM ET)Previous Close$0.02Today's Range$0.01 - $0.011552-Week Range$0.0061 - $0.0390Volume131,000 shsAverage Volume4,887 shsMarket Capitalization$340,600.00P/E RatioN/ADividend YieldN/ABeta4.68 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Receive ERGO News and Ratings via Email Sign-up to receive the latest news and ratings for ERGO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ERGO Previous Symbol CUSIPN/A CIK1408299 Webwww.entiabio.com Phone971-228-0709Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$260,000.00 Price / Sales1.31 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares34,060,000Market Cap$340,600.00 Next Earnings DateN/A OptionableNot Optionable Entia Biosciences (OTCMKTS:ERGO) Frequently Asked Questions What is Entia Biosciences' stock symbol? Entia Biosciences trades on the OTCMKTS under the ticker symbol "ERGO." Has Entia Biosciences been receiving favorable news coverage? News headlines about ERGO stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Entia Biosciences earned a news sentiment score of 0.6 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. Who are some of Entia Biosciences' key competitors? Some companies that are related to Entia Biosciences include True Drinks (TRUU), Nutra Pharma (NPHC), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE), Beleave (BE) and ImmuDyne (IMMD). What other stocks do shareholders of Entia Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Entia Biosciences investors own include United States Brent Oil Fund (BNO), National Bank of Canada (NA), Velocity Data (VCT), AAR (AIR), Lendlease Group (LLC), Constellation Brands (STZ), Mid-America Apartment Communities (MAA), iShares Transportation Average ETF (IYT), ABM Industries (ABM) and American River Bankshares (AMRB). Who are Entia Biosciences' key executives? Entia Biosciences' management team includes the folowing people: Dr. Marvin S. Hausman M.D., Chairman and Chief Science & Technology Officer (Age 78)Mr. Timothy A. Timmins, CEO & Pres (Age 62)Mr. Elliot A. L. Shelton Esq., Sec. and Director (Age 69)William Meyer, Head of Production How do I buy shares of Entia Biosciences? Shares of ERGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Entia Biosciences' stock price today? One share of ERGO stock can currently be purchased for approximately $0.01. How big of a company is Entia Biosciences? Entia Biosciences has a market capitalization of $340,600.00 and generates $260,000.00 in revenue each year. What is Entia Biosciences' official website? The official website for Entia Biosciences is http://www.entiabio.com. How can I contact Entia Biosciences? Entia Biosciences' mailing address is 13565 SW TUALATIN-SHERWOOD ROAD. SUITE 800, SHERWOOD OR, 97140. The biotechnology company can be reached via phone at 971-228-0709. MarketBeat Community Rating for Entia Biosciences (OTCMKTS ERGO)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 48 (Vote Outperform)Underperform Votes: 64 (Vote Underperform)Total Votes: 112MarketBeat's community ratings are surveys of what our community members think about Entia Biosciences and other stocks. Vote "Outperform" if you believe ERGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ERGO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment?